Pyxis Oncology, Inc. announced that it has received clearance for its two Investigational New Drug (IND) applications from the US FDA to initiate Phase I clinical trials.
[Pyxis Oncology, Inc.]
Home Newsletters Extracellular Matrix News Pyxis Oncology Announces FDA Clearance of Two IND Applications
